Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials. - Wikidata - wikimedia - TriplyDB

Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials.

Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials.

http://www.wikidata.org/entity/Q37665039

about

Medications for substance use disorders (SUD): emerging approaches.

P2860

Q47731975-F6C71BD0-7D15-40DA-8045-616288DC6EC1

P2860

Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials.

http://www.wikidata.org/entity/Q37665039

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Guarding the Gate: Remote Stru ...... recision in Depression Trials.

@en

Guarding the Gate: Remote Stru ...... recision in Depression Trials.

@nl

type

label

Guarding the Gate: Remote Stru ...... recision in Depression Trials.

@en

Guarding the Gate: Remote Stru ...... recision in Depression Trials.

@nl

prefLabel

Guarding the Gate: Remote Stru ...... recision in Depression Trials.

@en

Guarding the Gate: Remote Stru ...... recision in Depression Trials.

@nl

P1433

Q37665039-C16E91C4-8EEB-40BD-BE51-0D3A5484DC76

P1476

Q37665039-97BCF6CA-B2E7-4327-986D-5C875534B950

P2093

Q37665039-1A35B848-81C4-47BA-A88D-604215F1947B

Q37665039-3A4E3621-B500-4D16-A144-02F4A9F284DB

Q37665039-692F0F0D-2F50-4D29-9999-76E85002351D

Q37665039-86B0CFBA-03ED-441A-8985-AD6A4D947D35

Q37665039-93E9E12D-302A-41D1-8DE3-1EC579F00A29

Q37665039-A362E116-B461-46F1-B1DB-AA2A935CD4F0

Q37665039-FB629001-B923-420F-AC23-0839D1FE6081

P2860

Q37665039-01B3EC82-8612-4D1E-B679-3107E23B8343

Q37665039-14C81958-1490-46FC-8D29-7E78B5A1EA63

Q37665039-1BA6CA98-8206-4E9B-9B66-B68E09B083F4

Q37665039-291CC949-0AAA-4EFE-A3F3-393B5CE5C68A

Q37665039-2BBF292B-A6D4-4005-B871-8C605E97155A

Q37665039-63003A05-5FDE-4C72-B844-8759EA115986

Q37665039-65EC3D9E-EF0D-4500-878B-53009D877B01

Q37665039-79BD2A2E-6969-4CB3-946F-8428B768B25B

Q37665039-80A53339-03AF-4719-BD04-4671093FE076

Q37665039-8577893B-2554-41CA-B8C6-6D803B7755D7

P304

Q37665039-56844170-9736-495A-8223-19FDD2D924D1

P31

Q37665039-F7848F94-1C3B-47F5-AF13-5312FEEE47CF

P356

Q37665039-102C52AA-949E-403D-BFFC-6FB6F5A1991E

P407

Q37665039-B12B769D-8DD9-4B1E-B01C-AAFC95E1D14B

P433

Q37665039-1303BF69-6F5D-4ACA-8991-89BDC52FC062

P478

Q37665039-8F2935FC-03F3-4413-8301-2A938F860B9E

P577

Q37665039-962E8528-88A9-4EA5-A2D4-F7AF680FDAB1

P698

Q37665039-AD3825F6-9818-474D-83A7-FE3CAD6D002E

P932

Q37665039-473BF428-53D8-40A3-A069-F1868B3C1906

P356

JCP.0000000000000669

P1433

Journal of Clinical Psychopharmacology

P1476

Guarding the Gate: Remote Stru ...... recision in Depression Trials.

@en

P2093

David Mischoulon

http://www.w3.org/2001/XMLSchema#string

David Mou

http://www.w3.org/2001/XMLSchema#string

James Pooley

http://www.w3.org/2001/XMLSchema#string

Lee Baer

http://www.w3.org/2001/XMLSchema#string

Marlene P Freeman

http://www.w3.org/2001/XMLSchema#string

Martina J Flynn

http://www.w3.org/2001/XMLSchema#string

Maurizio Fava

http://www.w3.org/2001/XMLSchema#string

P2860

Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development

The failure of placebo-controlled studies. ECNP Consensus Meeting, September 13, 1997, Vienna. European College of Neuropsychopharmacology.

A structured interview guide for the Hamilton Depression Rating Scale.

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.

Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.

Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).

Diagnosis and definition of treatment-resistant depression.

Placebo response in depression.

Redefining affective disorders: relevance for drug development.

P304

176-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0000000000000669

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28187008

http://www.w3.org/2001/XMLSchema#string

P932

5325248

http://www.w3.org/2001/XMLSchema#string